Predicting surgery results for advanced ovarian cancer
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at results from surgery to remove as much advanced ovarian cancer as possible after chemotherapy. Participating hospitals are in Italy and Canada.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are being treated for ovarian cancer at one of these hospitals: Gemelli in Rome (Italy), Trillium-Credit Valley in Mississauga (Canada), or Princess Margaret in Toronto (Canada).
- You are healthy enough to have surgery to remove as much of the cancer as possible.
- Your cancer is at stage III or IV (it has spread outside the pelvis).
- You will have or have had chemotherapy first, and then surgery to remove remaining cancer (interval surgery).
- You do not have low-grade serous, clear cell, mucinous, or non-epithelial types of ovarian cancer (if this information is known).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of three targeted drugs (olaparib, durvalumab, and bevacizumab) as a first treatment for advanced ovarian cancer. It aims to shrink tumors before possible surgery, potentially improving outcomes.
This trial tests whether doing surgery with small incisions (minimally invasive) instead of a large cut is safe and effective for advanced ovarian cancer after chemo. It may mean a faster recovery while still removing the cancer.
This study looks back at different surgical methods (open or minimally invasive) used for early-stage epithelial ovarian cancer. It aims to compare outcomes and help doctors choose the best approach.
This study looks at how well a minimally invasive surgery (laparoscopic debulking) can remove tumor in people with advanced epithelial ovarian cancer. It may help doctors compare whether this approach is safe and effective for patients who need either upfront surgery or surgery after chemotherapy.
This study looks at women with advanced ovarian cancer to see if doctors can predict the type of tumor and how well surgery will go before the operation. It aims to help tailor treatment and improve outcomes.
This study looks back at records of people with advanced ovarian cancer to see if changing the order of their treatments might help them live longer. It focuses on those who had a certain type of surgery at a French hospital between 2010 and 2022.
Hear when a new Ovarian Cancer Stage III trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.